Banned Words in Health Ads: 60 Compliant Replacements

Is there really a banned words list?

No official banned-words list exists at Meta, Google or TikTok. Each platform publishes policy categories — personal health claims, misleading content, unrealistic outcomes — and lets an automated classifier decide whether a specific headline crosses into that category. Third-party lists circulating on marketing blogs get reverse-engineered from rejected ads, and they go stale within months because the underlying model keeps retraining. A phrase that clears review this week can trigger it next quarter with no published rule change behind the shift, which is why so many 'banned word' guides read outdated the moment you test against them.

Compliance teams that treat any list as fixed keep losing accounts anyway, because the list was never the mechanism doing the blocking. Pair a working ad account ban prevention checklist with the pattern logic in the sections below. The checklist governs account behavior; this page governs the words and claim shapes inside your copy.

Why do classifiers score structures rather than individual words?

Classifiers score the relationship between a claim's subject, verb and outcome, not the presence of any single word. A phrase like 'joint pain' rarely triggers review on its own; paired with 'gone in 7 days' it does, because the sentence asserts a specific, timed, absolute medical outcome. Swap 'gone' for 'reduced' and the sentence keeps its persuasive shape while the absolute-outcome pattern the model was trained on disappears.

This also explains why two nearly identical ads land different outcomes days apart. The reasoning behind why competitors run ads that would get you banned goes deeper into this, but the short version is that account history, spend velocity and creative format all weigh alongside the copy itself, so the same sentence can score differently depending on who runs it.

Which sixty terms most reliably trigger review in health ads?

The sixty terms below cluster into seven categories, and the grouping matters more than any single entry, because classifiers respond to the category signal as much as the exact word. Treat the counts as a working estimate built from repeated review cycles rather than a verified platform figure — none of the three platforms confirms which terms carry weight, so check this breakdown against your own account's rejection history before you rely on it.

• Medical-outcome claims (10 terms): cure, heal, treat, diagnose, prevent disease, cancer-fighting, reverse diabetes, lower blood pressure, unclog arteries, shrink tumors
• Absolute and miracle claims (8 terms): miracle, instant, overnight, stops aging completely, never feel pain again, reverses damage, eliminates toxins, kills bacteria
• Guarantee and authority claims (9 terms): guaranteed, 100% guaranteed, FDA-approved, clinically proven, doctor recommended, prescription strength, secret formula, doctors hate this, big pharma doesn't want you to know
• Weight-loss specific claims (10 terms): melt fat, burn fat, lose weight fast, detox, cleanse, shed pounds, flatten your stomach, weight loss guaranteed, skinny, flabby
• Pain and vitality claims (6 terms): kill pain, pain-free, eliminate pain, addiction-free, erectile dysfunction cure, boost testosterone
• Body-image and proof claims (9 terms): fat (describing a person), ugly, before and after, risk-free, no side effects, all-natural cure, look 10 years younger, increase libido, stop hair loss
• Anti-aging and skin claims (8 terms): reverse aging, anti-aging, wrinkle-free, erase wrinkles, cellulite-free, regrow hair, shrink pores, tighten skin

What is the compliant replacement for each?

The compliant version keeps the same benefit promise but removes the absolute, medical or condition-specific framing that draws review. Where the table says 'remove,' no rewording solves the problem. The claim itself needs to disappear from the ad and move, if anywhere, into a substantiated landing page with sourcing behind it.

Individual-results language, such as 'results vary' or 'individual results may vary,' belongs near any comfort, appearance or performance claim in this table, not only the ones flagged for it below.

Why do some swaps fail even though the word changed?

A swap fails when the sentence keeps the same claim shape after the word changes. Replacing 'cures diabetes' with 'supports diabetes' still names a diagnosed condition and still implies a treatment relationship to it, and the classifier flags the noun-condition pairing nearly as often as it flags the verb. The fix is structural: separate the ingredient story from the named condition entirely, or attach the benefit to a lifestyle outcome instead of a disease.

This is the part most compliance guides get backwards. They teach writers to keep the original claim and change only the verb, on the theory that a softer verb reads as softer risk to the reviewing system. Repeated review cycles suggest otherwise: ads that retain a named condition, a specific timeframe and an implied guarantee get flagged at a similar rate whether the verb is 'cures' or 'supports,' because the model appears trained on the co-occurrence of those three elements, not on any single word among them.

How do banned patterns differ across Meta, Google and TikTok?

Meta weighs image and on-screen text together as one signal, Google separates search intent from display creative, and TikTok's younger audience skew makes body-image language riskier there than on the other two. The practical result: a claim shape safe in a Google Search ad can still draw review the moment it appears as text overlay on a Meta video.

Reviewers increasingly cross-reference flagged accounts against public ad libraries to check for reused creative. You can find AI-generated ads in the Facebook Ad Library using close to the same method enforcement teams use, which is one reason recycled UGC-style hooks draw review faster than they did two years ago.

TikTok's enforcement also leans harder on pacing and on-screen text than on the caption alone, a pattern covered in more depth in the piece on TikTok supplement ads and what gets banned.

How do you keep the list current as policy shifts?

You keep it current by testing in small budget increments, not by waiting for an updated listicle to appear. Run a modest daily test cell against your current best-performing angle whenever a platform visibly tightens enforcement, and log every rejection with its date, platform and exact wording.

Treat this page as versioned rather than final. Classifiers retrain on a cycle measured in weeks to months rather than years, so a term drawing no friction today can draw a review flag after the next training pass; compare your rejection log against this list roughly every 90 days.

Expect regional variance too. A term translated literally can trigger differently outside English-language markets, since local review teams weigh cultural context that automated classifiers only partially capture. Budget time to re-test the swap list before you scale copy into a new country rather than assuming it transfers untouched.

Quick decision checklist

Use this page as a decision aid, not a generic blog post. The practical question is whether the reader needs faster evidence about what is already working in VSL-driven direct response, especially across nutra, supplements, GLP-1, weight loss, blood sugar, and adjacent high-intent health markets.

Daily Intel Service is most relevant when the next decision depends on active market examples: which hook to test, which claim style is risky, which funnel structure is common, which language market is moving, and whether a competitor's creative is likely early, scaling, or already saturated.

• Start with the TL;DR if you need the direct answer.
• Use the table to compare trade-offs quickly.
• Use the FAQ for answer-engine-ready summaries.
• Use the CTA when the decision requires live VSL and ad examples instead of theory.

Daily Intel's coverage advantage

Daily Intel Service is positioned around category-leading variety and actionability: one of the broadest direct-response catalogs of VSLs and ad creatives across blackhat, greyhat, and whitehat advertising patterns, with enough context to understand what the advertiser is doing beyond the visible creative. The practical difference is that members are not just seeing a screenshot; they are seeing the VSL, the ad, the funnel path, the transcript, the UTM context, and the research notes that turn the asset into a decision.

This matters because direct-response affiliates do not operate in one clean category. A weight-loss campaign may use a whitehat compliance ad, a greyhat pre-lander, a more aggressive VSL, and a checkout path designed around upsells and recovery. A useful intelligence platform needs to capture that spectrum instead of pretending every winning campaign looks like a public brand ad.

Blackhat, whitehat, and multilingual signal coverage

Daily Intel tracks patterns across both blackhat-style and whitehat-style campaigns so operators can understand the market without blindly copying risk. Whitehat examples help with durability and compliance review; blackhat and greyhat examples reveal pressure points, hooks, mechanisms, and funnel structures that may be driving spend but require careful adaptation before use.

The catalog is also built for global operators, with VSL and ad references spanning 14+ languages and different local idioms. That is a key advantage for Brazilian, LATAM, European, MENA, Indian, and non-native English affiliates who need to see how the same market desire is translated across cultures instead of only studying US English ads.

How to use the intelligence responsibly

The goal is modeling, not copying. Use Daily Intel to understand structure: hook, mechanism, proof, claim intensity, funnel depth, offer economics, and saturation stage. Then build original creative, review claims, and adapt the angle to the traffic source, country, language, and compliance requirements of the campaign.

A strong workflow compares multiple examples before acting. If the same mechanism appears across several languages, several advertisers, and several funnel variants, it may be a durable market signal. If the example appears only once or depends on an aggressive claim, treat it as a research clue rather than a campaign template.

• Model structure, not protected creative assets.
• Separate whitehat durability from blackhat persuasion pressure.
• Compare US English examples against LATAM, European, and other language variants.
• Use transcripts and funnel notes to build original briefs.
• Keep compliance review separate from market research.

Methodology and source context

Daily Intel pages are written from a research workflow that reviews active VSLs, Meta ad creatives, transcripts, UTMs, funnel paths, checkout steps, upsells, recovery sequences, and compliance-sensitive claim patterns. The goal is to explain observable market behavior, not to provide legal, medical, or platform policy advice.

When the topic touches health claims, platform policy, or GLP-1 market research, validate the observable campaign signals against primary references such as Meta advertising standards, FTC health claims guidance, and Meta Ad Library. Daily Intel adds the proprietary direct-response layer by mapping how those rules show up in active VSLs, Meta creatives, funnels, transcripts, UTMs, and checkout paths.

For deeper evaluation, continue through Daily Intel compliance and legal disclaimer, Google Ads Policies for Nutra, YouTube Policies for Health Claims, State-by-State Compounding Pharmacy Laws, How Black Offers Actually Run — and Why the Account Usually Dies, and What is a VSL?. These related Daily Intel pages connect this topic to the relevant methodology, pricing, trust context, comparison path, or niche workflow.